Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apyx Medical (APYX) Inventory (2016 - 2025)

Apyx Medical (APYX) has disclosed Inventory for 16 consecutive years, with $9.8 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Inventory rose 14.11% year-over-year to $9.8 million, compared with a TTM value of $9.8 million through Dec 2025, up 14.11%, and an annual FY2025 reading of $9.8 million, up 14.11% over the prior year.
  • Inventory was $9.8 million for Q4 2025 at Apyx Medical, down from $10.3 million in the prior quarter.
  • Across five years, Inventory topped out at $12.0 million in Q3 2022 and bottomed at $4.5 million in Q1 2021.
  • Average Inventory over 5 years is $9.0 million, with a median of $9.7 million recorded in 2022.
  • The sharpest move saw Inventory decreased 24.0% in 2021, then surged 99.37% in 2022.
  • Year by year, Inventory stood at $6.8 million in 2021, then skyrocketed by 74.05% to $11.8 million in 2022, then dropped by 15.89% to $9.9 million in 2023, then dropped by 13.37% to $8.6 million in 2024, then increased by 14.11% to $9.8 million in 2025.
  • Business Quant data shows Inventory for APYX at $9.8 million in Q4 2025, $10.3 million in Q3 2025, and $8.2 million in Q2 2025.